SCHEDULE 13G: Sio Capital Management Divests Entire Stake in Q32 Bio Inc., Filing Shows 0% Ownership

Sio Capital Management, LLC has filed a Schedule 13G indicating it no longer holds any beneficial ownership in Q32 Bio Inc., reducing its stake to 0% as of March 31, 2025.

Summary

• Sio Capital Management, LLC, a Delaware limited liability company and registered investment adviser, has reported 0% beneficial ownership in Q32 Bio Inc.'s common stock.
• The filing, a Schedule 13G, indicates that as of March 31, 2025, Sio Capital Management, LLC holds no shares with sole or shared voting or dispositive power.
• The aggregate amount beneficially owned by Sio Capital Management, LLC is 0.00 shares, representing 0% of the class of securities.
• Sio Capital Management, LLC certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Q32 Bio Inc.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the complete divestment by an institutional investor, which can be interpreted as a lack of confidence, although the filing itself is purely factual and provides no reasons for the divestment.

Negatives

• Sio Capital Management, LLC has divested its entire beneficial ownership in Q32 Bio Inc., now holding 0% of the common stock. This complete divestment by an investment adviser could be perceived as a negative signal regarding the firm's outlook on Q32 Bio Inc.

Future Outlook

The document does not provide any forward-looking statements or guidance from Q32 Bio Inc. or Sio Capital Management, LLC regarding future performance or strategic direction.

Management Comments

• Sio Capital Management, LLC certifies that, to the best of its knowledge and belief, the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

This filing is a standard disclosure of beneficial ownership change by an institutional investor. It does not provide specific insights into broader industry trends or competitive landscape, but reflects an investment firm's decision regarding its position in a biotechnology company.

Stakeholder Impact

• Shareholders of Q32 Bio Inc. may view the complete divestment by Sio Capital Management, LLC as a negative signal, potentially influencing their perception of the company's future prospects.

Key Dates

Keywords

Q32 Bio Inc., Sio Capital Management, SEC filing, Schedule 13G, beneficial ownership, common stock, investment adviser, divestment, ownership change